rs3751667

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_022773.4(LMF1):​c.306G>A​(p.Thr102Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.254 in 1,612,686 control chromosomes in the GnomAD database, including 56,067 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 7115 hom., cov: 33)
Exomes 𝑓: 0.25 ( 48952 hom. )

Consequence

LMF1
NM_022773.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.13

Publications

54 publications found
Variant links:
Genes affected
LMF1 (HGNC:14154): (lipase maturation factor 1) Involved in triglyceride metabolic process. Predicted to be integral component of membrane. Predicted to be active in endoplasmic reticulum membrane. Implicated in familial lipase maturation factor 1 deficiency. [provided by Alliance of Genome Resources, Apr 2022]
LMF1 Gene-Disease associations (from GenCC):
  • lipase deficiency, combined
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 16-954554-C-T is Benign according to our data. Variant chr16-954554-C-T is described in ClinVar as Benign. ClinVar VariationId is 1246959.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.422 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LMF1NM_022773.4 linkc.306G>A p.Thr102Thr synonymous_variant Exon 2 of 11 ENST00000262301.16 NP_073610.2 Q96S06-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LMF1ENST00000262301.16 linkc.306G>A p.Thr102Thr synonymous_variant Exon 2 of 11 5 NM_022773.4 ENSP00000262301.12 Q96S06-1

Frequencies

GnomAD3 genomes
AF:
0.289
AC:
43957
AN:
152038
Hom.:
7102
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.402
Gnomad AMI
AF:
0.319
Gnomad AMR
AF:
0.278
Gnomad ASJ
AF:
0.236
Gnomad EAS
AF:
0.406
Gnomad SAS
AF:
0.438
Gnomad FIN
AF:
0.130
Gnomad MID
AF:
0.244
Gnomad NFE
AF:
0.231
Gnomad OTH
AF:
0.277
GnomAD2 exomes
AF:
0.277
AC:
68629
AN:
247618
AF XY:
0.280
show subpopulations
Gnomad AFR exome
AF:
0.406
Gnomad AMR exome
AF:
0.288
Gnomad ASJ exome
AF:
0.220
Gnomad EAS exome
AF:
0.407
Gnomad FIN exome
AF:
0.139
Gnomad NFE exome
AF:
0.227
Gnomad OTH exome
AF:
0.258
GnomAD4 exome
AF:
0.250
AC:
365474
AN:
1460530
Hom.:
48952
Cov.:
37
AF XY:
0.255
AC XY:
184971
AN XY:
726506
show subpopulations
African (AFR)
AF:
0.415
AC:
13882
AN:
33460
American (AMR)
AF:
0.289
AC:
12895
AN:
44610
Ashkenazi Jewish (ASJ)
AF:
0.223
AC:
5828
AN:
26130
East Asian (EAS)
AF:
0.392
AC:
15541
AN:
39682
South Asian (SAS)
AF:
0.421
AC:
36341
AN:
86220
European-Finnish (FIN)
AF:
0.152
AC:
7995
AN:
52768
Middle Eastern (MID)
AF:
0.259
AC:
1494
AN:
5768
European-Non Finnish (NFE)
AF:
0.230
AC:
255634
AN:
1111542
Other (OTH)
AF:
0.263
AC:
15864
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
15386
30772
46158
61544
76930
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9016
18032
27048
36064
45080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.289
AC:
44011
AN:
152156
Hom.:
7115
Cov.:
33
AF XY:
0.287
AC XY:
21343
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.402
AC:
16674
AN:
41484
American (AMR)
AF:
0.278
AC:
4256
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.236
AC:
817
AN:
3468
East Asian (EAS)
AF:
0.406
AC:
2100
AN:
5174
South Asian (SAS)
AF:
0.437
AC:
2106
AN:
4816
European-Finnish (FIN)
AF:
0.130
AC:
1376
AN:
10602
Middle Eastern (MID)
AF:
0.221
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
0.231
AC:
15743
AN:
68006
Other (OTH)
AF:
0.276
AC:
583
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1582
3163
4745
6326
7908
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
446
892
1338
1784
2230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.253
Hom.:
16167
Bravo
AF:
0.301
Asia WGS
AF:
0.414
AC:
1441
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Feb 03, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.64
DANN
Benign
0.29
PhyloP100
-1.1
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3751667; hg19: chr16-1004554; COSMIC: COSV51897207; API